Curtiss-Wright Corporation (CW)

Executive Summary / Key Takeaways

• Nuclear Power as a Structural Growth Engine: Curtiss-Wright is positioned to nearly quadruple its commercial nuclear revenue to $1.5 billion by the mid-2030s, driven by SMR development, AP1000 reactor orders anticipated in 2026, and $80 billion in U.S. government commitments to new nuclear capacity—creating a multi-decade tailwind that diversifies the company beyond defense spending cycles.

• Margin Inflection Through Operational Excellence: The "Pivot to Growth" strategy delivered 120 basis points of operating margin expansion to a record 18.6% in 2025, with management guiding for another 30-60 basis points in 2026, demonstrating that operational improvements are structural rather than cyclical and supporting 11-15% EPS growth despite modest revenue guidance.

• Defense Electronics Positioned for AI-Driven Modernization: Partnerships with NVIDIA (NVDA) for ruggedized AI computing and a MOSA-aligned product portfolio position CW at the center of Pentagon priorities like Golden Dome and next-generation fighters, though timing risks from continuing resolutions create near-term order volatility that management conservatively guides around.

• Capital Allocation Discipline Amid Record Cash Generation: Record free cash flow of $554 million (111% conversion) in 2025 funded $465 million in share repurchases while maintaining capacity for acquisitions, with net debt/EBITDA of 0.46x providing flexibility to invest in capacity for 12-16 reactors annually without diluting shareholders.

• Key Risk Asymmetry: While 58% government exposure creates headline risk from budget cycles, the $4.1 billion backlog (up 18%) and long-term naval contracts provide revenue visibility that mitigates volatility; the real swing factor is whether SMR development accelerates from prototypes to production orders by 2027, which could drive meaningful upside to the mid-decade revenue target.

Setting the Scene: The Tier 2 Supplier With Tier 1 Moats

Curtiss-Wright Corporation, incorporated in 1929 from the Wright Brothers' pioneering aviation legacy, has evolved far beyond its aerospace origins into a critical technology provider that makes money by solving the hardest engineering problems in the world's most demanding markets. The company operates as a Tier 2/3 supplier, but this label understates its economic power. Unlike commodity component manufacturers, CW provides highly engineered products where failure is not an option—nuclear reactor coolant pumps, submarine propulsion systems, and AI-enabled battlefield computing. This positioning creates natural monopolies: once qualified on a platform like the Virginia-class submarine or F-35 fighter, CW becomes the sole source for decades of aftermarket revenue.

The significance lies in the industry structure. Defense spending is entering a supercycle, with the FY2026 budget approaching $1 trillion and NATO allies committing to 5% of GDP by 2035. Simultaneously, commercial nuclear power is experiencing its first renaissance in forty years, driven by data center power demands and decarbonization mandates. CW sits at the intersection of these trends, but its real advantage lies in the integration of these capabilities. While Moog (MOG.A) focuses on precision motion control and BWXT (BWXT) dominates reactor cores, CW provides the auxiliary systems that make both work—pumps, valves, controls, and electronics that represent $110+ million per AP1000 reactor and critical content on every U.S. Navy nuclear vessel.

The company's "Pivot to Growth" strategy represents a fundamental shift from defense-cycle dependence to diversified, technology-driven growth. The strategy manifests in three concrete ways: the Operational Growth Platform that systematically expands margins, a focus on higher-growth commercial nuclear and defense electronics markets, and capital allocation that prioritizes shareholder returns through buybacks while funding R&D above sales growth. The result is a business that generated 12% revenue growth and 20% operating income growth in 2025—proving that operational leverage is real and sustainable.

Technology, Products, and Strategic Differentiation: The Nuclear and AI Moats

Curtiss-Wright's competitive advantage rests on proprietary technologies that are impossible to replicate without decades of investment and regulatory approval. In Naval Power, the company is one of few qualified suppliers of Reactor Coolant Pumps (RCPs) for Westinghouse AP1000 reactors, with historical content of $110+ million per plant. The real opportunity lies in expanding this content to $220-330 million per plant by supplying additional valves, controls, and sensors—a 2-3x increase that management is actively pursuing with Westinghouse. This transforms CW from a component supplier into a systems integrator, capturing more value per reactor while deepening customer switching costs.

The SMR opportunity compounds this advantage. CW has invested in multiple SMR developers and expects the market to transition from design to prototypes by 2026 and production by decade's end. With capacity to produce 12-16 reactors annually, CW could generate incremental revenue exceeding $1.5 billion by mid-next decade from SMRs alone. Orders for X-energy's advanced reactor are already contributing to growth, and the Rolls-Royce (RYCEY) SMR partnership leverages CW's reactor protection systems expertise. The technology moat here is regulatory: NRC certification for nuclear components takes years and millions of dollars, creating barriers that no startup can overcome.

In Defense Electronics, CW's partnership with NVIDIA to integrate Blackwell GPUs into ruggedized deployable systems represents a leap ahead of traditional COTS suppliers. The Fabric 100 product line provides 100 gigabit connectivity for sensor processing, while validation in the Microsoft (MSFT) Azure ecosystem brings enterprise-class computing to the tactical edge. The Pentagon's MOSA (Modular Open Systems Approach) mandate requires interoperable solutions, and CW's alignment with SOSA, CMOSS, and SOSA standards positions it to win content on over 400 defense platforms. This grants significant pricing power: while competitors fight over commodity board-level modules, CW sells integrated subsystems with 27.3% operating margins—260 basis points higher than 2024.

The surface technology services business, while smaller, demonstrates CW's ability to monetize its materials science expertise. Shot peening and laser peening extend component life in both commercial aerospace and defense applications, creating recurring revenue from maintenance contracts. This technology supports the Aerospace Industrial segment's 17% operating margin and 16% backlog growth, proving that even mature markets can generate attractive returns when served with proprietary processes.

Financial Performance & Segment Dynamics: Evidence of Structural Improvement

The 2025 results validate the thesis that operational excellence is driving permanent margin expansion. Total sales grew 12% to $3.5 billion, but operating income surged 20% to $634 million, expanding margins by 120 basis points to a record 18.6%. This 1.7x operating leverage—where income grows faster than sales—demonstrates that the Operational Growth Platform is a continuous improvement engine. Free cash flow of $554 million with 111% conversion proves that earnings quality is high and working capital management is disciplined.

Segment performance reveals the strategic mix shift. Naval Power led with 18% sales growth and 23% order growth, driving backlog up 27% to $2.58 billion. Nuclear projects have long lead times, providing revenue visibility through 2028 and beyond. The segment's 15.4% operating margin declined 20 basis points due to acquisition dilution and higher R&D for next-gen SMR designs, but this investment is essential for capturing the $1.5 billion SMR opportunity.

Defense Electronics delivered the highest profitability at 27.3% operating margin, up 260 basis points, on 12% sales growth. The book-to-bill of 0.96x in 2025 appears concerning, but it is primarily a result of timing from continuing resolutions. Over $50 million in orders pushed from Q3 to later periods; the full-year book-to-bill would have been 1.1x without these delays. This indicates that demand remains robust despite bureaucratic procurement slowdowns. The segment's $991 million backlog remains flat year-over-year, but the pipeline is healthy and aligned with modernization priorities.

Aerospace Industrial grew sales 5% and operating income 12%, expanding margins 110 basis points to 17.0%. This segment outperformed global macro conditions in general industrial markets. The 16% backlog growth to $505 million provides cushion against potential Boeing (BA) or Airbus (EADSY) production volatility. Management's guidance for 5-7% sales growth and 90-110 basis points of margin expansion in 2026 reflects confidence that operational excellence can overcome cyclical headwinds.

The balance sheet supports aggressive capital deployment. Net debt of $1.15 billion represents just 0.46x EBITDA. The company repurchased $465 million in shares in 2025—nearly 2% of shares outstanding—while increasing capital expenditures 50% to $90 million to support nuclear capacity expansion. CW can invest for growth, return cash to shareholders, and still maintain capacity for acquisitions. The $200 million debt repayment planned for December 2026 will further reduce interest expense, supporting EPS growth.

Outlook, Management Guidance, and Execution Risk

Management's 2026 guidance reveals a company confident in its trajectory but realistic about near-term headwinds. Organic sales growth of 6-8% embeds conservatism around ground defense timing and assumes no AP1000 order—despite management's explicit expectation of receiving one. The 30-60 basis points of operating margin expansion to 18.9-19.2% is achievable given the $12 million in operational excellence savings realized in 2025. Diluted EPS growth of 11-15% to $14.70-$15.15 implies 1.5x earnings leverage on sales growth, consistent with the structural margin improvement thesis.

The segment outlook tells a more nuanced story. Naval Defense is projected to grow 5-7%, but this excludes any AP1000 contribution. AP1000 revenue follows a "bell curve" over five years, with initial material orders in 2026 accelerating in 2027. If the company secures a U.S. order for the 10 new reactors supported by $80 billion in government funding, revenue could exceed guidance by $100+ million annually at peak production.

Ground Defense is guided down 4-6% due to the 0.96x book-to-bill in Defense Electronics. Management explicitly stated this is timing, not lost business, but the conservative guide reflects uncertainty around how quickly orders will recover after the continuing resolution ends. The risk is that delays stretch beyond 90 days, pressuring Q1 2026 results. However, the tactical communications business that was most impacted is short-cycle, meaning it can ramp quickly once funding flows.

Commercial Aerospace guidance of 10-12% growth assumes continued narrow-body and wide-body production increases. The FAA's 25-hour cockpit voice recorder mandate creates a retrofit opportunity for CW's flight recorder solutions. The company jointly developed this technology with Honeywell (HON), and with 3,000+ registered U.S. aircraft requiring upgrades, this represents a multi-year revenue stream. This high-margin aftermarket revenue diversifies CW from OEM production rates.

The SMR development timeline is critical. Management expects prototypes by 2026 and initial production orders by decade's end. This 8-10 year horizon requires patience, but the $1.5 billion revenue target is credible given CW's capacity and design wins. The company's investments in multiple SMR developers help diversify the risk of regulatory delays or utility design preferences.

Risks and Asymmetries: What Could Break the Thesis

The most material risk is execution on the nuclear opportunity. While the AP1000 order is anticipated in 2026, Westinghouse could delay procurement or choose alternative suppliers for non-RCP content. The $1.5 billion SMR revenue target assumes successful prototype development and regulatory approval—a process that has historically taken over a decade. If SMR deployment stalls, CW's commercial nuclear growth would be limited to maintenance and outage services on existing reactors.

Defense concentration remains a structural vulnerability. With 58% of sales to government end-users, CW is exposed to budget cycles and political risk. The continuing resolution impact in 2025 demonstrates this sensitivity—over $50 million in Defense Electronics orders were delayed. While naval defense contracts are multi-year and insulated, a major defense budget cut could impact the $2.58 billion Naval Power backlog. The mitigating factor is that CW's content is on mission-critical platforms like the Columbia-class submarine and Ford-class carrier, which are prioritized even in budget constraints.

Supply chain dependencies create margin pressure. Management noted that while they attempt to pass through cost increases, there are no assurances that higher prices can effectively be passed through. The 2022 electronic supply chain disruption impacted Defense Electronics, and future disruptions in specialized materials could compress margins. CW's operational excellence initiatives—targeting $12 million in annual savings—provide a buffer, but sustained inflation could offset these gains.

Competitive threats in defense electronics are intensifying. While CW claims to be a leader in embedded computing and AI, larger competitors like Mercury Systems (MRCY) and Collins Aerospace, a subsidiary of RTX Corporation (RTX), have greater scale and R&D resources. The NVIDIA partnership is a differentiator today, but if competitors secure similar alliances or if open standards like MOSA commoditize the hardware layer, CW's 27.3% Defense Electronics margins could face pressure.

The tariff risk illustrates supply chain fragility. Management estimated $30 million in tariff impacts for 2025, with mitigation strategies reducing the net impact to $10 million. However, broader trade disruptions could increase costs beyond what pricing can offset, particularly in the Aerospace Industrial segment.

Competitive Context: Where CW Stands Apart

Against Moog, CW's advantage is integration. While Moog leads in precision motion control with 10.45% EBIT margins, CW's defense electronics and naval systems offer higher margins and greater revenue growth. Moog's mechanical focus lacks the digital layer that CW provides through its NVIDIA partnership and Fabric 100 products. However, Moog's space systems penetration exceeds CW's, representing a growth area where CW lags.

Versus ITT (ITT), CW's defense concentration is both risk and reward. ITT's diversified industrial pumps business provides stability but limits growth to 8% total revenue growth compared to CW's 12%. CW's 20.32% operating margin exceeds ITT's 18.85%, reflecting higher-value content. ITT's lower debt-to-equity provides more acquisition capacity, but CW's superior cash flow conversion funds internal growth.

BWX Technologies is CW's pure-play nuclear competitor. BWXT's 18% revenue growth matches CW's Naval Power segment, but its 9.26% operating margin is below CW's 15.4% due to BWXT's focus on reactor cores where CW supplies higher-margin auxiliary equipment. BWXT's higher debt-to-equity ratio constrains investment, while CW's 0.46 ratio supports capacity expansion. However, BWXT's exclusive naval reactor contracts give it unassailable positions that CW can only complement.

Crane Company (CR) competes in aerospace valves and industrial components, but its 16.13% operating margin and 6.78% revenue growth trail CW's performance. Crane's scale in industrial markets exceeds CW's, but CW's defense and nuclear content is more strategic and higher-margin. CW's 19.43% ROE exceeds Crane's 17.91%, demonstrating superior capital efficiency.

The key differentiator across all peers is CW's free cash flow generation. At 111% conversion, CW converts nearly every dollar of earnings into cash, funding both growth investments and shareholder returns without dilution. This compares favorably to peers with higher capital intensity. CW can self-fund its nuclear capacity expansion and SMR investments while returning $465 million annually to shareholders.

Valuation Context: Pricing in Execution

At $663.56 per share, Curtiss-Wright trades at 44.2x price-to-free-cash-flow and 7.2x enterprise value-to-revenue. These multiples reflect the company's unique positioning in high-growth nuclear and defense electronics markets. The P/E ratio of 51.6x is influenced by the company's high cash conversion and capacity for buybacks.

Peer comparisons provide context. ITT trades at 29.1x P/FCF and 3.8x EV/Revenue, but with lower growth and margins. BWXT trades at 62.9x P/FCF despite 9.26% operating margins, reflecting its pure-play nuclear exposure. CW's valuation premium to ITT is justified by superior growth and margins, while its discount to BWXT's P/FCF reflects greater diversification.

The enterprise value of $25.3 billion represents approximately 7.2x TTM revenue, which is aligned with a company guiding to 6-8% organic growth with expanding margins. The key valuation driver will be execution on the nuclear opportunity. If CW achieves the $1.5 billion commercial nuclear target by 2030, today's valuation will appear conservative. Conversely, if SMR development stalls, the multiple could compress to peer levels.

Balance sheet strength supports the valuation. Net debt of $1.15 billion and debt-to-EBITDA of 0.46x provide capacity for acquisitions. The $400 million increase in share repurchase authorization in 2025 signals management's confidence that the stock remains attractive, while the 0.14% dividend yield reflects a disciplined capital allocation focused on growth.

Conclusion: A Nuclear-Powered Industrial Compound

Curtiss-Wright has engineered a rare combination: exposure to the nuclear renaissance—a multi-decade, non-cyclical growth driver—with operational excellence that systematically expands margins and converts earnings to cash. The 2025 results validate that the "Pivot to Growth" strategy is a structural improvement, delivering 20% operating income growth on 12% revenue growth while generating record free cash flow.

The central thesis hinges on two variables: the timing of AP1000 orders and the pace of SMR commercialization. Management's confidence in a 2026 AP1000 order, combined with capacity for 12-16 reactors annually, suggests revenue upside not reflected in guidance. The SMR opportunity represents the potential to transform CW from a defense contractor into a commercial energy infrastructure provider, fundamentally altering its valuation multiple.

The primary risk is execution—delays in nuclear orders or prolonged defense budget dysfunction could pressure the stock. However, the $4.1 billion backlog, long-term naval contracts, and proven operational resilience provide downside protection. For investors, CW offers a unique way to invest in the nuclear renaissance without the regulatory concentration risk of BWXT or the cyclical industrial exposure of ITT and Crane. The premium valuation reflects this scarcity value, justified by the combination of margin expansion, cash generation, and multi-decade nuclear tailwinds.